|
Originally published In Press as doi:10.1074/jbc.M001685200 on March 24, 2000
J. Biol. Chem., Vol. 275, Issue 25, 19115-19120, June 23, 2000
Species Differences between Rat and Mouse CCKA
Receptors Determine the Divergent Acinar Cell Response to the
Cholecystokinin Analog JMV-180*
Baoan
Ji ,
Alan S.
Kopin§, and
Craig D.
Logsdon ¶
From the Department of Physiology, University of
Michigan, Ann Arbor, Michigan 48109-0622 and § Tupper
Research Institute, New England Medical Center,
Boston, Massachusetts 02111
Received for publication, March 1, 2000
 |
ABSTRACT |
The cholecystokinin (CCK) analog JMV-180 acts as
a partial agonist in rats and a full agonist in mice. Whether this
functional variability is due to species differences in CCK receptor
structure or to alterations in the cellular environment is unknown. To
address this question, an adenoviral construct encoding the rat
CCKA receptor (AdCCKAR) was used to
express the rat receptor in acini from CCKA receptor-deficient mice (CCKAR / ). Infection of
CCKAR / acini in vitro with
pAdCCKAR led to a time-dependent increase in
125I-CCK8 binding. The affinity for JMV-180 of
the adenovirally transferred rat and the endogenous mouse
CCKA receptors was not different. In native mouse acini,
JMV-180 acted as a full agonist (both stimulation and inhibition
of amylase release). In contrast, in mouse acini expressing
pAdCCKAR JMV-180 acted as a partial agonist (only
stimulation of amylase release). In addition, the pattern of protein
synthesis induced by JMV-180 in CCKAR / mouse acini
infected with AdCCKAR resembled the pattern observed in
wild-type rats (lack of inhibition) rather than the respective pattern
in wild-type mice (inhibition). These data suggest that species
differences in the CCKA receptor of rats and mice account
for the observed divergence in the acinar cell response to JMV-180.
 |
INTRODUCTION |
Gene transfer studies provide a powerful approach to investigate
the correlation between receptor structure and function. Manipulation
of the cDNA encoding a receptor followed by expression of the
mutant protein in a cell model allows detailed analysis of the role of
specific receptor domains and individual residues. This approach has
been widely utilized and has resulted in important advancement in our
understanding of G protein-coupled receptor signaling (1). However, it
has become increasingly apparent that the choice of cell model used for
gene transfer experiments significantly impacts the receptor properties
that are observed (2). Differentiated cells express specific subsets of
proteins that interact with G protein-linked receptors; examples
include G proteins, arrestins, G protein receptor kinases, and RGS
proteins (3). The cell model may therefore exert a major influence on the outcome of receptor structure-function studies.
Recently it was suggested that interspecies variation in cellular
milieu might explain observed differences between the drug-induced responses of the rat versus the mouse CCKA
receptor (4). In both species, CCKA receptors bind the
endogenous hormone cholecystokinin (CCK)1 with high affinity. A
similar pattern of cell signals and biological responses is in turn
triggered in both rats and mice. In contrast, the CCK analog JMV-180
acts as a partial agonist in the rat and a full agonist in the mouse
(5-7). Differences between partial and full CCK agonists are striking
in the pancreatic acinar cell. Full agonists (e.g. CCK-8)
show marked differences in biological effects at both physiologic and
supra-physiologic concentrations. At physiologic concentrations, full
agonists cause increases in acinar cell secretion, an oscillatory
pattern of intracellular Ca2+ concentration, stimulation of
protein synthesis, and little measurable increase in either inositol
1,4,5-trisphosphate or diacylgycerol. In contrast, high concentrations
of full agonists cause an inhibition of acinar cell secretion, a peak
and plateau pattern of intracellular Ca2+ concentration,
inhibition of protein synthesis, and large increases in inositol
1,4,5-trisphosphate and diacylgycerol. In mice, JMV-180, like CCK-8, is
a full agonist and shows a similar pattern of biphasic responses (5).
In contrast, when administered to rats, JMV-180 lacks the biphasic
response and only generates the pattern observed with low
concentrations of CCK-8 (5, 8).
The explanation for this interspecies variability is not clear. There
are 23 amino acid differences between the rat and mouse CCKA receptor sequences. Therefore, one possibility is that
interspecies polymorphisms in the CCKA receptor structure
account for the observed functional variability in the action of
JMV-180. An alternative explanation for the observed species dependence
of JMV-180 signaling is that there are significant differences between
acinar cells in rats and mice. A recent study supporting the latter
hypothesis showed that there were no major differences between the
binding or coupling of rat and mouse CCKA receptors when
the receptors were expressed in CHO cells (4). However, CHO cells are
fibroblastic cells derived from the Chinese hamster ovary and may not
accurately reflect the cellular context of a pancreatic acinar cell.
The initial goal of the current study was to express a functional rat
CCKA receptor in a mouse acinar cell and examine the responses to CCK-8 and JMV-180 in order to determine whether the physiologic cellular context influences the observed differences in
agonist activity. We utilized adenoviral-mediated gene transfer to
express rat CCKA receptors in pancreatic acini, because we have previously found this to be a highly efficient approach (9). To
avoid complications due to the presence of endogenous mouse CCKA receptors, we utilized acini prepared from
CCKA receptor-deficient mice (CCKAR / )
(10). We found that adenoviral infection allowed expression of ectopic
receptors to physiologic levels in nearly 100% of the cells within a
few hours. At the titers utilized in this study, adenovirally infected
acini secreted amylase and synthesized protein identically to
uninfected acini. Using this approach we observed that ectopically
expressed rat CCKA receptors mimicked the pattern of
biological responses (i.e. secretion and protein synthesis)
to CCK-8 and JMV-180 that is found in studies of wild-type rat acini.
These results contrast with what was observed with endogenous mouse
CCKA receptors. Taken together, these data indicate that
CCKA receptor structural differences account for the
divergence in JMV-180 activity in these two species and, furthermore,
illustrate the importance of investigating receptor function in the
context of physiologically relevant cell models.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Harlan Sprague-Dawley rats were obtained from
Harlan Inc. (Indianapolis, IN). CCKAR / mice were
generated as described previously (11). 129/SVIMJ control mice were
purchased from The Jackson Laboratory (Bar Harbor, Maine). Fura 2-AM
was purchased from Molecular Probes (Eugene, OR). Collagenase (CLSPA
grade) was purchased from Worthington Biochemicals (Freehold, NJ).
Sulfated CCK-8 was obtained from Bachem Bioscience Inc. (Torrance, CA).
Amylase 3 reagent was obtained from Sigma. Protein assay reagent was
obtained from Bio-Rad. [3H]Leucine was purchased from
Amersham Pharmacia Biotech. Trichloroacetic acid was from J. T. Baker Inc. [125I-Bolton-Houter]CCK8 (81,400 GBq/mm) was obtained from NEN Life Science Products. All other
materials were purchased from Sigma.
Construction of a Recombinant Adenovirus Encoding the Rat
CCKA Receptor--
A recombinant adenovirus encoding the
rat CCKA receptor was produced according to the method of
He et al. (12). Briefly, a
HindIII/BamHI fragment that encoded the
full-length rat CCKA receptor (13) (kindly provided by
S. A. Wank, National Institutes of Health, Bethesda, MD) was
blunted with Klenow and cloned into the EcoRV site of the
pAd-Track-CMV shuttle vector, producing pAd-Track-CMV-CCKAR
plasmid. Under the control of distinct CMV promoters, this plasmid
expresses the rat CCKA receptor and, in parallel, green
fluorescent protein (GFP). The construct was linearized with
PmeI and cotransfected together with the adenoviral backbone vector, pAd-Easy-1, into Escherichia coli strain BJ5183.
Recombinant cosmids were selected with kanamycin and screened by
BamHI and PacI digestion. The adenoviral
construct was then cleaved with PacI and transfected in a
packaging cell line (human embryonic kidney 293 cells). An adenovirus
(AdLacZ) expressing bacterial -galactosidase and GFP, each under the
control of a separate CMV promoter, was a gift from Dr. He (John
Hopkins Oncology Center, Baltimore, MD) and utilized as a control. The
recombinant virus was concentrated using a CsCl gradient. The titer of
the viral stocks was estimated based on the density of GFP-expressing
cells. Virus was stored in 10% glycerol at 80 °C in aliquots of
50 µl.
Preparation of Acini and Infection with the Virus--
Acini
were prepared by methods previously described (14). In brief, the
pancreas was excised from freely fed adult male Harlan Sprague-Dawley
rats or 129/SVIMJ mice. Acini were prepared by enzymatic digestion with
purified collagenase, followed by mechanical shearing. Acini were then
filtered through 150-µm Nitex mesh, purified by sedimentation through
4% bovine serum albumin in Dulbecco's modified Eagle's medium. The
acini were suspended in HEPES-Ringer buffer (HR) containing 1% bovine
serum albumin, 0.1 mg/ml soybean trypsin inhibitor, and 127 mM NaCl, 4.7 mM KCl, 1.06 mM
MgCl2, 1.28 mM CaCl2, 1.0 mM Na2HPO4, 10 mM
HEPES, 2 mM L-glutamine, and 10 mM D-glucose
and essential amino acids. The pH was adjusted to 7.4 and equilibrated
with 100% O2 before use. The acini of CCKAR
/ mice were infected with virus encoding the rat CCKAR.
Acini of wild-type mice and rats were infected with virus encoding
-galactosidase. All virus was used at ~107
plaque-forming unit/mg of protein. Virus was added to acini in 3 ml of
HR buffer for 10 min. The acini were then diluted with HR to 13 ml,
transferred to 100-mm dishes, and incubated at 37 °C in a humidified
5% CO2 atmosphere.
JMV-180 Competition Binding Assays--
The affinity of JMV-180
for acini expressing CCKARs was assessed by competition
binding experiments using 5 pM 125I-CCK-8 as
radioligand. All experiments were done in HR buffer with the bovine
serum albumin concentration adjusted to 0.1% and inclusion of 0.5 mg/ml bacitracin. Acini were incubated in polystyrene tubes at 37 °C
with increasing amounts of nonradioactive JMV-180 for 90 min;
preliminary studies showed that binding reached a steady-state by 90 min. Nonspecific binding was assessed in the presence of 100 nM unlabeled CCK-8. Acini were separated from unbound CCK
by centrifugation at 300 × g for 3 min and then washed twice with ice-cold 0.9% NaCl. The cells were then solubilized with 1 ml of 0.1 N NaOH, and radioactivity was quantified in a -counter. Protein content was determined on samples after counting. Binding affinity was calculated from JMV-180 competitive binding experiments using the Graphpad Prism 3.0 program (Graphpad Software Inc, San Diego, CA).
Analysis of CCK and JMV-180 Induced Increases in Intracellular
Ca2+ Concentration--
Analysis of intracellular
Ca2+ concentration was conducted using ratiometric imaging
of Fura-2-loaded cells as described previously (15). In brief, acini
were incubated with 5 µM fura 2-AM at 37 °C for 30 min
and then washed and resuspended in HR buffer. Fura-loaded acini were
transferred to a closed chamber, mounted on the stage of a Zeiss
Axiovert inverted microscope, and continuously superfused at 1 ml/min
with HR buffer and different concentrations of CCK-8 or JMV-180 at
37 °C. Measurement of emitted fluorescence and calibration of these
signals to yield a measurement of intracellular Ca2+ were
performed using an Attofluor digital imaging system (Rockville, MD), as
described previously (15).
Analysis of Amylase Secretion--
Amylase secretion in response
to CCK-8 or JMV-180 was measured as described previously (9). Briefly,
acini were washed and resuspended in HR at ~1 mg/ml. Aliquots of 3.5 ml were distributed into 25-ml polycarbonate Erlenmeyer flasks and
incubated with increasing concentrations of CCK-8 or JMV-180 at
37 °C for 30 min. Incubation was terminated by centrifugation of
1-ml aliquots for 15 s at 15,000 × g. The
concentration of amylase in the medium was measured using the Amylase 3 reagent. Results were expressed as a percentage of initial acinar
amylase content.
Incorporation of Amino Acid into Protein--
The effects of
CCK-8 and JMV-180 on protein synthesis were examined using
[3H]leucine as described previously with minor
modifications (16). Briefly, 1-ml aliquots of acinar suspension (1 mg
of total protein) were preincubated at 37 °C for 30 min with either
CCK-8 or JMV-180 using duplicate flasks for each concentration studied.
[3H]Leucine (2 µCi/ml) was then added, and
incorporation was terminated 20 min later by diluting with an equal
volume of ice-cold 0.9% NaCl containing 20 mM unlabeled
leucine. After centrifugation, the sediments were washed with 4 °C
saline and disrupted by sonication in 0.75 ml of distilled water. The
protein was then precipitated with equal volumes of ice-cold 20%
trichloroacetic acid. After 30 min, the trichloroacetic acid
precipitates were washed twice with ice-cold 10% trichloroacetic acid
and dissolved in 400 µl 0.1 N NaOH. Aliquots were removed
for protein assay, and the remaining samples were measured in a liquid
scintillation counter. Data for each experimental condition were
normalized to the percentage of [3H]leucine incorporation
in control acini ([3H]leucine incorporated/total
[3H]leucine added/mg of protein × 100).
Statistical Analysis--
Statistical analysis was carried out
using Graphpad Prism 3.0 program (Graphpad Software Inc, San Diego,
CA). Differences between individual conditions and controls were tested
with analysis of variance and the Newman-Keuls multiple range test.
Two-way analysis of variance was used to analyze the experiments that had a factorial design. In the analysis, differences were considered significant when p < 0.05.
 |
RESULTS |
Adenoviral-mediated Expression of a Rat CCKA
Receptor--
CCKA receptors are expressed in the exocrine
pancreas of both rats and mice. Species differences in the structure of
these receptors are relatively minor, with only 23 amino acids that diverge between respective CCKAR homologs (Fig.
1). The major structural difference is a
seven-amino acid insertion found in the third intracellular loop of the
mouse CCKA receptor. Dissimilarities have previously been
noted between the functional effects of the CCK analog JMV-180 in these
two species (5, 6). To determine whether these divergent biological
responses were the result of variability in the structure of the
receptors or due to differences in cellular environment, we utilized an
adenoviral construct encoding the rat CCKA receptor
(AdCCKAR). This virus also expresses GFP under the
control of a distinct CMV promoter. In initial experiments, efficiency of the infecting virus was assessed by monitoring GFP levels
in acini by fluorescence microscopy. It was observed that adenoviral-mediated gene expression was titer-dependent
(data not shown). Using a titer of ~107 plaque-forming
unit/mg of acinar protein, nearly 100% of the acini expressed GFP
(Fig. 2). Higher titers did not further
improve efficiency (data not shown).

View larger version (85K):
[in this window]
[in a new window]
|
Fig. 1.
Comparison of mouse and rat CCKA
receptor structure. Boxes indicate residues that
differ. Dark lines above the sequences indicate predicted
locations of transmembrane domains. CCKA receptors from
these two species differ by 23 amino acid residues. The major
difference is a seven-amino acid insert in the third cytoplasmic loop
of the mouse receptor. The mouse and rat sequences shown are from
GenBankTM accession numbers AF015963 and M88096, respectively.
|
|

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 2.
Adenoviral infection of pancreatic acini is
highly efficient. Acini were prepared and were infected with
107 plaque-forming units of pAdCCKAR/mg of
acinar protein. This adenovirus expresses the rat CCKA
receptor and GFP under the control of separate CMV promoters. After a
16-h incubation, acini were observed with fluorescent microscopy and
photographed with a digital camera. Acini expressing virally delivered
GFP display a green fluorescence. The same field of acini was then
photographed under bright-field conditions for comparison. Results show
that nearly 100% acini are infected.
|
|
Adenoviral-mediated gene expression was also
time-dependent. To define the level of receptor expression,
125I-CCK binding was assessed at different times after
infection with AdCCKAR. Acini isolated from
CCKAR / mice showed no CCK binding before infection.
After infection of CCKAR / acini with AdCCKAR, a time-dependent increase in
125I-CCK binding was observed (Fig.
3). Specific binding levels comparable with those of acini from CCKAR +/+ mice were observed ~4
h after infection. Maximal binding levels ~5-fold over control were
observed after 16 h. Therefore, all biological responses were
assessed 4 h post-infection.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Time-course of adenoviral-mediated
CCKAR gene expression in pancreatic acini. Specific
binding of 125I-CCK was compared between acini prepared
from wild-type mice (black) and infected with pAdLacZ and
those from CCKAR / mice infected with
pAdCCKAR for various times (striped). Binding
was conducted using 125I-CCK (5 pM) with or
without excess unlabeled CCK-8 (100 nM) for an additional
90 min at 37 °C. Acini were then washed, and the amount of
displaceable binding was determined. The rat CCKA receptor
expression levels in infected acini from CCKAR / acini
increased over time. Binding levels similar to those observed in acini
from control CCKAR +/+ mice were obtained within 4 h
after infection. Data shown are expressed as the percentage of binding
observed in acini from wild-type mice (11 ± 0.5% total/mg of
protein, n = 4) and are means ± S.E. from 4-6
separate experiments.
|
|
Binding and Signaling of the Rat CCKA Receptor
Expressed in Mouse Acini--
To determine the affinity of the rat
CCKA receptor expressed in the mouse acinar cells,
competition binding experiments were performed after infection of acini
from CCKAR / mice with AdCCKAR. When
expressed in acini from CCKAR / mice, the rat receptor showed high affinity displaceable 125I-CCK binding that was
comparable with affinities observed with either mouse or rat wild-type
acini (data not shown). JMV-180 competed for binding of
125I-CCK (Fig. 4). The
affinity of JMV-180 for the rat receptor expressed in the mouse
CCKAR / acinar cell was not significantly different from the affinity of the native mouse receptor assessed in acini from
CCKAR +/+ mice (Ki = 1.4 ± 0.1 versus 1.5 ± 0.39 nM, n = 4, p > 0.05). Infection with control adenovirus had no effect on receptor binding (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Characteristics of JMV-180 binding to mouse
pancreatic acini expressing native mouse or ectopic rat
CCKA receptors. Competitive binding assays were
conducted with acini either from wild-type control mice infected with
pAdLacZ (squares) or from CCKA
receptor-deficient mice infected with pAdCCKAR
(triangles). Four hours after infection acini were incubated
with 125I-CCK (5 pM) in the presence of
indicated concentrations of JMV-180 for 90 min at 37 °C. Cells were
then washed, and radioactivity associated with the cells was assessed.
Nonspecific binding was determined using 100 nM CCK-8. Data
are expressed as % total binding/mg of protein and are means ± S.E. from four independent experiments.
|
|
To characterize the coupling of the rat CCKAR to
calcium-mediated signaling when expressed in mouse acini, cells were
loaded with Fura-2AM, and intracellular Ca2+ levels were
determined by ratiometric fluorescence imaging. CCKAR /
acini without virus infection did not respond to CCK-8 (Fig. 5A) or JMV-180 (data not
shown); however, they did show a normal response to stimulation with
bombesin. Acini from CCKAR / mice infected with
AdCCKAR showed an oscillatory pattern of Ca2+
increase after stimulation with a low concentration and a peak and
plateau type of response when stimulated with a high concentration of
CCK-8 (Fig. 5B). The response of
AdCCKAR-infected acini to CCK-8 was similar to the pattern
previously observed in acini prepared from CCKAR +/+ mice
or from rats (5). Responses to JMV-180 were not markedly different
between acini prepared from wild-type rats and mice. Both showed
oscillatory Ca2+ responses (Fig. 5, C and
E). However, subtle differences were noted. In mice, the
oscillations did not return to base line, whereas in rats the
oscillations did return to base-line levels. Ca2+ responses
to JMV-180 of acini from CCKAR / mice infected with AdCCKAR resembled the oscillatory activity observe with
wild-type rat acini, i.e. with a full return to base line
between spikes. It should be noted that these differences in
Ca2+ signaling were somewhat variable and did not allow a
clear distinction between species.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
Rat CCKA receptors couple with
increases in intracellular Ca2+ in mouse acinar cells.
Acini were infected with adenovirus for 4 h and then loaded with
Fura 2-AM for 30 min before ratiometric imaging was performed.
A, acini from CCKA / mice were infected with
pAdLacZ and then stimulated with either CCK-8 (1 nM) or
bombesin (Bn, 1 nM) for the time indicated.
B, acini from CCKA / mice were infected with
pAdCCKAR and then stimulated with either a low (10 pM) or a high (100 pM) concentration of CCK-8
as indicated. C, control mouse acini were infected with
pAdLacZ and then stimulated with a maximal concentration of JMV-180 (1 µM). D, acini from CCKA / mice
were infected with pAdCCKAR and then stimulated with
JMV-180 (1 µM). E, acini from a rat were
infected with pAdLacZ and then stimulated with JMV-180 (1 µM). Shown are representative traces from at least 25 acinar cells from one of at least 4 independent experiments.
|
|
Biological Responses to Activation of Rat CCKA
Receptors Expressed in Mouse Acini--
To assess the biological
activity of mouse acini expressing recombinant rat CCKA
receptors we analyzed the effect of receptor activation on both amylase
secretion and protein synthesis. In initial experiments, the effect of
adenoviral infection per se on pancreatic acinar cell
amylase secretion was determined. Infection of acini isolated from
CCKAR +/+ mice with a control GFP-expressing virus had no
significant effect on basal (1.0 ± 0.4 versus 1.8 ± 0.4% total/30 min, n = 3, p > 0.05) or maximal (5.2 ± 1.9 versus 5.1 ± 1.1%
total/30 min, n = 3, p > 0.05) CCK-8
stimulated amylase release. Next, the
concentration-dependent release of amylase stimulated with
either CCK-8 or JMV-180 was assessed. Acini from CCKAR
/ mice were compared with acini from control mice and control rats
(Fig. 6). In both rat and wild-type mice
acini, a typical biphasic dose-response curve for CCK-8 stimulation of amylase release was observed. The percentage of total amylase released
in 30 min was less in mice (Fig. 6A) than in rats (Fig. 6C), as has been reported previously (17). In both species, concentrations of CCK-8 above 1 nM caused a reduction in
amylase release. By contrast, markedly different patterns of response to stimulation with JMV-180 were observed in rats versus
CCKA +/+ mice. In CCKA +/+ mice, JMV-180 caused
a biphasic stimulation of amylase release, with prominent inhibition
observed at supramaximal concentrations (Fig. 6A). In rats,
JMV-180 showed monophasic concentration dependence without causing any
decrease of amylase release even at supramaximal concentrations (Fig.
6C). In acini from CCKAR / mice infected
with AdCCKAR the amylase response pattern to CCK-8 was
biphasic, similar to that observed in acini from control rats and mice.
The level of amylase released was comparable with what was observed in
native mouse acini. However, in mouse acini expressing the rat
CCKA receptor, the pattern of amylase release stimulated by
JMV-180 was similar to that observed in control rats (monophasic)
rather than control mice (biphasic). Although JMV-180 stimulated
amylase secretion at low concentrations in rat
AdCCKAR-infected mouse acini, no inhibition of secretion
was observed even at concentrations up to 1 µM (Fig.
6B).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Species differences in secretory responses to
JMV-180 are determined by the receptor structure. Acini from
control mice, CCKA receptor knockout mice, or rats were
infected with virus. Amylase secretion in response to increasing
concentrations of CCK-8 and JMV-180 was measured at 4 h.
A, acini from control mice infected with the pAdLacZ control
virus. Both CCK-8 and JMV-180 had biphasic effects on amylase release.
B) acini from CCKA receptor / mice infected
with pAdCCKAR. CCK-8 stimulated a biphasic effect on
amylase release, but JMV-180 did not show high dose inhibition.
C) acini from control rats infected with pAdLacZ control
virus. CCK-8 stimulated a biphasic effect on amylase release, but
JMV-180 did not show high dose inhibition. Results are means ± S.E. for 3-5 experiments.
|
|
To evaluate the effect of receptor activation on protein synthesis, the
incorporation of [3H]leucine into protein was analyzed.
Differences were noted in the effects of both CCK-8 and JMV-180 on
protein synthesis in rats versus mice. In control mice,
CCK-8 caused an inhibition of protein synthesis that was significant at
a concentration of 0.1 nM (Fig.
7A). In rat acini, CCK-8
inhibited protein synthesis, but these effects required CCK-8
concentrations above 1 nM (Fig. 7C). In control
mice, JMV-180 caused a decrease in protein synthesis (Fig.
7A). In contrast, in rat acini, JMV-180 did not inhibit protein synthesis even at concentrations up to 1 µM (Fig.
7C). The pattern of effects of CCK-8 and JMV-180 on protein
synthesis in acini isolated from CCKA / mice infected
with AdCCKAR resembled the observed pattern in the rat. In
mouse acini expressing ectopic rat CCKA receptors, CCK-8
did not significantly inhibit protein synthesis at concentrations below
1 nM (Fig. 7B). In addition, as in rat acini,
JMV-180 did not inhibit protein synthesis at any concentration.
Overall, the mouse CCKAR / acini expressing rat
CCKARs biologically resembled wild-type rat rather than
wild-type mouse acini.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 7.
Species differences in protein synthesis
responses to JMV-180 are determined by CCKA receptor
structure. Acini from control mice, CCKA receptor
/ mice, or rats were infected with virus. Protein synthesis in
response to increasing concentrations of CCK-8 and JMV-180 was assessed
at 4 h. A, acini prepared from control mice were
infected with pAdLacZ control virus. Both CCK-8 and JMV-180 inhibited
protein synthesis. B, acini from CCKA receptor
/ mice infected with pAdCCKAR. CCK-8 caused prominent
inhibition at concentrations of 1 nM or above. JMV-180 did
not inhibit protein synthesis at any concentration tested.
C, acini prepared from rats were infected with pAdLacZ.
CCK-8 inhibited protein synthesis at concentrations of 3 nM
or above. JMV-180 did not inhibit protein synthesis and caused a small
increase in synthesis at the highest concentrations. Results are
means ± S.E. for 3-5 experiments.
|
|
 |
DISCUSSION |
In this study we expressed rat CCKA receptors in the
context of the mouse pancreatic acinar cell. Although the mouse
CCKA receptor and the rat CCKA receptor are
structurally highly homologous, several important differences in
ligand-induced activity were observed. Activation of the mouse
CCKA receptor with the CCK-8 analog JMV-180 had a biphasic
effect on secretion, as has been previously noted (5). However,
activation of the rat CCKA receptor in the context of the
mouse acini did not show high dose inhibition. This pattern of response
is similar to what is observed in wild-type rat acinar cells (5).
Furthermore, activation of the mouse CCKA receptor with
JMV-180 inhibited protein synthesis, as has been previously described
(5). In contrast, no inhibitory effect was noted when the rat
CCKA receptor was activated in the context of the mouse
acinar cell. Thus, the rat CCKA receptor expressed in the
context of the mouse acinar cell responds similarly to what is observed
in wild-type rat acini and contrasts with the CCKAR-induced
effects observed in wild-type mouse acini. Therefore, structural
differences in the CCKAR protein are the most likely explanation for the observed divergence in effects of JMV-180 between
the two species.
This study utilized adenoviral-mediated gene transfer to express
receptors in pancreatic acini. Adenoviral infection has been shown to
be a highly efficient means of gene transfer to this cell type (9, 14,
18). In the current study using GFP expression to monitor gene
transfer, we observed nearly 100% efficiency. This high level was
confirmed in experiments imaging Ca2+ release in individual
acinar cells, where every cell infected with receptor bearing
adenovirus showed a response to CCK-8. Adenoviral infection at the
titers used in the current study did not perturb receptor binding,
Ca2+ signaling, secretion, or protein synthesis. However,
previously we noted that adenoviral infection induces an increase in
NF- B activation (14). Furthermore, at titers higher than those
utilized in the current study, significant deleterious effects were
noted (data not shown). Therefore, adenoviral titer is a critical
parameter in this type of study. To avoid the complications of altering viral titers we utilized time as a means of controlling receptor expression levels. Receptor levels were observed to increase rapidly after infection, and levels that approximated those found in control acini were observed within 4 h. The biological response observed with adenovirus-mediated receptor expression approximated the biology
observed in control cells, illustrating the power of this approach for
the study of receptor function.
CCK-8 stimulates an identical pattern of response in both species as
well as in mouse acini recombinant rat CCKA receptors. In
both species, the CCKA receptor is thought to mediate its
signaling through interactions with heterotrimeric G proteins of the
Gq family (19, 20). An interesting aspect of CCK receptor
activation is the dependence on agonist concentration for coupling to
separate intracellular signaling events that in turn lead to different biological outcomes (21). At low physiologic concentrations, CCK-8
stimulates an oscillatory Ca2+ response (22), stimulates
secretion and protein synthesis (21), and increases Erk activity (23).
However, at high concentrations, CCK-8 inhibits secretion and protein
synthesis (5), disrupts the cytoskeleton (24), activates stress
responses including activation of Jun kinase (25) and NF B (14), and
induces an acute edematous pancreatitis (26). Thus, the nature of the
signaling pathways that differentiate between the effects of high and
low concentrations of CCK is potentially of great significance.
The JMV-180 analog is a useful tool in the investigation of CCK
receptor signaling. JMV-180 is a synthetic analogue of the COOH-terminal heptapeptide of CCK, with the structure
t-butoxycarbonyl-Tyr(SO3)-Nle-Gly-Trp-Nle-Asp-2-phenylethyl ester (8) (Nle is norleucine). The most important modification in this
CCK analog is in the carboxyl terminus, where aspartate is linked by an
ester bond to phenylamine instead of the peptide bond linkage to the
terminal-amidated phenylalanine in CCK. Other modifications in this
molecule confer increased stability but likely do not affect biological
activity (27). In the rat JMV-180 acts as a partial agonist. Activation
of the rat CCKA receptor with JMV-180 elicits biological
responses associated with the low concentrations of CCK but not with
high concentrations (7). Therefore, JMV-180 has become a popular tool
for differentiating between the effects of low and high concentrations
of CCK in the rat. In contrast, in the mouse JMV-180 acts as a full
agonist, activating the complete range of signaling mechanisms
associated with the CCKA receptor (5).
One possible explanation for the species difference in the effects of
JMV-180 is that mouse and rat pancreatic acinar cells present a
different environment to the CCKA receptor. Little is know
about the patterns of expression of proteins important to receptor
signaling in these cells. Based on work in other cell types, it is well
established that receptor function is influenced by a variety of
cellular proteins including heterotrimeric G proteins, G protein-linked
receptor kinases, arrestins, and RGS proteins (3). Unfortunately,
little is known concerning the identity and qualitative distribution of
these regulatory molecules within pancreatic acinar cells. However,
acinar cells are highly differentiated and specialized for the
synthesis, storage, and secretion of digestive enzymes. In this regard,
cells from rats and mice share more similarities with each other than
with most other cell types. Activation of receptors in the context of
the rat acinar cell caused the release of a greater percentage of total
cellular amylase content than did activation of either rat or mouse
CCKA receptors in the acini prepared from mice. This
species difference has been previously noted (17). Despite these
intracellular differences, activation of the rat CCKA
receptor in the context of the mouse acini gave a pattern of effects
identical to what is observed in rat acini. Therefore, fundamental
differences in receptor structure rather than the cellular environment
per se most likely explain the observed differences in
JMV-180 effects in rats versus mice.
No appreciable differences were observed in the effects of JMV-180 when
the rat and mouse CCKA receptors were expressed in CHO
cells (4). This suggests that the context of the pancreatic acinar cell
is required to unravel functional differences between rat and mouse
CCKA receptors. One limitation of the previous study in CHO
cells was that it is not possible to investigate the effects of
receptor activation on secretion in this model. The only biological response analyzed in the CHO cells was Ca2+ release, and no
differences between rat and mouse CCKA receptor stimulation
were noted. However, it is possible that the differences between rats
and mice in this parameter are small. We observed only subtle
differences between the effects of JMV-180 on Ca2+ release
in rats and mice. In rats, the response to a supramaximal concentration
of JMV-180 was exclusively oscillatory, as has been reported previously
(22). In mice, the response was also oscillatory in nature, but at
least initially, the oscillations did not return to base line. It is of
note that activation of the rat CCKA receptor in the
context of the mouse acinar cell produced a pattern of Ca2+
release that was more similar to the rat than to the control mouse,
although the observed differences were subtle and difficult to
quantify. It is possible that differences in the effects of JMV-180 on
rat versus mouse CCKA receptors on CHO cells
might be detectable if other cellular parameters, such as protein
synthesis, were measured.
In conclusion, expression of the rat CCKA receptor in the
context of receptor-deficient mouse pancreatic acinar cells indicates that differences in receptor structure contribute to the divergent effects of JMV-180 between species. The pattern of responses to JMV-180
activation of rat CCKA receptors expressed in the
context of the mouse pancreatic acinar cell was entirely compatible
with what is observed in wild-type rat pancreatic acinar cells and clearly different than what is observed in wild-type mouse acini. Therefore, these data indicate that differences in CCKA
receptor structure between rats and mice lead to distinctive
interactions with JMV-180 and explain the observed species dependent
differences in biological activity.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK52067 and DK46767 (to A. S. K.) and University of Michigan Gastrointestinal Peptide Center Grant DK34933.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Physiology, Box 0622, University of Michigan, 7710 Medical Sciences
Bldg. II, Ann Arbor, MI 48109-0622. Tel.: 734-763-2539; Fax:
734-936-8813; E-mail: clogsdon@umich.edu.
Published, JBC Papers in Press, March 24, 2000, DOI 10.1074/jbc.M001685200
 |
ABBREVIATIONS |
The abbreviations used are:
CCK, cholecystokinin;
CCKR, CCK receptor;
CHO, Chinese hamster ovary;
CMV, cytomegalovirus;
GFP, green fluorescent protein;
HR, HEPES-Ringer
buffer.
 |
REFERENCES |
| 1.
|
Roth, N. S.,
Lefkowitz, R. J.,
and Caron, M. G.
(1991)
Adv. Exp. Med. Biol.
308,
223-238
|
| 2.
|
Logsdon, C. D.
(1999)
Life Sci.
64,
369-374
|
| 3.
|
Ferguson, S. S.,
Zhang, J.,
Barak, L. S.,
and Caron, M. G.
(1998)
Life Sci.
62,
1561-1565
|
| 4.
|
Ghanekar, D.,
Hadac, E. M.,
Holicky, E. L.,
and Miller, L. J.
(1997)
J. Pharmacol. Exp. Ther.
282,
1206-1212
|
| 5.
|
Matozaki, T.,
Martinez, J.,
and Williams, J. A.
(1989)
Am. J. Physiol.
257,
G594-G600
|
| 6.
|
Gaisano, H. Y.,
Klueppelberg, U. G.,
Pinon, D. I.,
Pfenning, M. A.,
Powers, S. P.,
and Miller, L. J.
(1989)
J. Clin. Invest.
83,
321-325
|
| 7.
|
Sato, S.,
Stark, H. A.,
Martinez, J.,
Beaven, M. A.,
Jensen, R. T.,
and Gardner, J. D.
(1989)
Am. J. Physiol.
257,
G202-G209
|
| 8.
|
Stark, H. A.,
Sharp, C. M.,
Sutliff, V. E.,
Martinez, J.,
Jensen, R. T.,
and Gardner, J. D.
(1989)
Biochim. Biophys. Acta
1010,
145-150
|
| 9.
|
Nicke, B.,
Tseng, M.-J.,
Fenrich, M.,
and Logsdon, C. D.
(1999)
Am. J. Physiol.
276,
G499-G506
|
| 10.
|
Kopin, A. S.,
Nguyen, M.,
Chiu, M.,
Beinborn, M.,
Schmitz, F.,
Wang, D.,
Carey, M.,
Kanarek, R.,
Mathes, W. F.,
Langhans, N.,
and Ardman, B.
(1996)
Regul. Pept.
64,
96 (abstr.)
|
| 11.
|
Kopin, A. S.,
Mathes, W. F.,
McBride, E. W.,
Nguyen, M.,
Al-Haider, W.,
Schmitz, F.,
Bonner-Weir, S.,
Kanarek, R.,
and Beinborn, M.
(1999)
J. Clin. Invest.
103,
383-391
|
| 12.
|
He, T. C.,
Zhou, S.,
da Costa, L. T., Yu, J.,
Kinzler, K. W.,
and Vogelstein, B.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2509-2514
|
| 13.
|
Wank, S. A.,
Harkins, R.,
Jensen, R. T.,
Shapira, H.,
de Weerth, A.,
and Slattery, T.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
3125-3129
|
| 14.
|
Han, B.,
and Logsdon, C. D.
(1999)
Am. J. Physiol.
277,
C74-C82
|
| 15.
|
Yule, D. I.,
Tseng, M.-J.,
Williams, J. A.,
and Logsdon, C. D.
(1993)
Am. J. Physiol.
265,
G999-G1004
|
| 16.
|
Logsdon, C. D.,
and Williams, J. A.
(1986)
Am. J. Physiol.
250,
G440-G447
|
| 17.
|
Bianchi, B. R.,
Miller, T. R.,
Witte, D. G.,
and Lin, C. W.
(1994)
J. Pharmacol. Exp. Ther.
268,
996-1002
|
| 18.
|
Padfield, P. J.,
Elliott, A. C.,
and Baldassare, J. J.
(1998)
Pflugers Arch. Eur. J. Physiol.
436,
782-787
|
| 19.
|
Huang, S. C.,
Fortune, K. P.,
Wank, S. A.,
Kopin, A. S.,
and Gardner, J. D.
(1994)
J. Biol. Chem.
269,
26121-26126
|
| 20.
|
Yule, D. I.,
Baker, C. W.,
and Williams, J. A.
(1999)
Am. J. Physiol.
276,
G271-G279
|
| 21.
|
Matozaki, T.,
Goke, B.,
Tsunoda, Y.,
Rodriguez, M.,
Martinez, J.,
and Williams, J. A.
(1990)
J. Biol. Chem.
265,
6247-6254
|
| 22.
|
Yule, D. I.,
and Williams, J. A.
(1992)
J. Biol. Chem.
267,
13830-13835
|
| 23.
|
Duan, R. D.,
and Williams, J. A.
(1994)
Am. J. Physiol.
267,
G401-G408
|
| 24.
|
Schafer, C.,
Ross, S. E.,
Bragado, M. J.,
Groblewski, G. E.,
Ernst, S. A.,
and Williams, J. A.
(1998)
J. Biol. Chem.
273,
24173-24180
|
| 25.
|
Dabrowski, A.,
Grady, T.,
Logsdon, C. D.,
and Williams, J. A.
(1996)
J. Biol. Chem.
271,
5686-5690
|
| 26.
|
Steer, M. L.,
and Saluja, A. K.
(1993)
in
The Pancreas: Biology, Pathobiology, and Disease.
(Go, V. L. W.
, DiMagno, E. P.
, Gardner, J. D.
, Lebenthal, E.
, Reber, H. A.
, and Scheele, G. A., eds)
, pp. 489-526, Raven Press, Ltd., New York
|
| 27.
|
Galas, M. C.,
Lignon, M. F.,
Rodriguez, M.,
Mendre, C.,
Fulcrand, P.,
Laur, J.,
and Martinez, J.
(1988)
Am. J. Physiol.
254,
G176-G182
|
| 28.
| Deleted in proof
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Ji, S. Gaiser, X. Chen, S. A. Ernst, and C. D. Logsdon
Intracellular Trypsin Induces Pancreatic Acinar Cell Death but Not NF-{kappa}B Activation
J. Biol. Chem.,
June 26, 2009;
284(26):
17488 - 17498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dufresne, C. Seva, and D. Fourmy
Cholecystokinin and gastrin receptors.
Physiol Rev,
July 1, 2006;
86(3):
805 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Archer-Lahlou, C. Escrieut, P. Clerc, J. Martinez, L. Moroder, C. Logsdon, A. Kopin, C. Seva, M. Dufresne, L. Pradayrol, et al.
Molecular Mechanism Underlying Partial and Full Agonism Mediated by the Human Cholecystokinin-1 Receptor
J. Biol. Chem.,
March 18, 2005;
280(11):
10664 - 10674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, X. Chen, and J. A. Williams
Regulation of CCK-induced amylase release by PKC-{delta} in rat pancreatic acinar cells
Am J Physiol Gastrointest Liver Physiol,
October 1, 2004;
287(4):
G764 - G771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Reeve Jr., S. V. Wu, D. A. Keire, K. Faull, P. Chew, T. E. Solomon, G. M. Green, and T. Coskun
Differential bile-pancreatic secretory effects of CCK-58 and CCK-8
Am J Physiol Gastrointest Liver Physiol,
March 1, 2004;
286(3):
G395 - G402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Sans, M. J. DiMagno, L. G. D'Alecy, and J. A. Williams
Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F
Am J Physiol Gastrointest Liver Physiol,
August 8, 2003;
285(3):
G517 - G528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, J. A. S. Edwards, C. D. Logsdon, S. A. Ernst, and J. A. Williams
Dominant Negative Rab3D Inhibits Amylase Release from Mouse Pancreatic Acini
J. Biol. Chem.,
May 10, 2002;
277(20):
18002 - 18009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Prost, S. Sheahan, D. Rannie, and D. J. Harrison
Adenovirus-mediated Cre deletion of floxed sequences in primary mouse cells is an efficient alternative for studies of gene deletion
Nucleic Acids Res.,
August 15, 2001;
29(16):
e80 - e80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Poosti, L. di Malta, D. Gagne, N. Bernad, J.-C. Galleyrand, C. Escrieut, S. Silvente-Poirot, D. Fourmy, and J. Martinez
The Third Intracellular Loop of the Rat and Mouse Cholecystokinin-A Receptors Is Responsible for Different Patterns of Gene Activation
Mol. Pharmacol.,
April 13, 2001;
58(6):
1381 - 1388.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Han, B. Ji, and C. D. Logsdon
CCK independently activates intracellular trypsinogen and NF-{kappa}B in rat pancreatic acinar cells
Am J Physiol Cell Physiol,
March 1, 2001;
280(3):
C465 - C472.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|